Biography:

Sara Mikhael obtained her bachelor's degree in pharmacy from the Lebanese American University. With high distinction, she obtained her Master's degree in Cancer and Therapeutics at the Barts Cancer Institute in London with a thesis entitled "Impact of tumor heterogeneity on the response to kinase targeted therapies". She is currently completing her doctoral studies in medical and biological sciences at L’Université Saint-Joseph de Beyrouth (USJ) in collaboration with the American University of Beirut (AUB). Her project focuses on the use of metabolism-altering drugs, simvastatin and metformin, in ovarian cancer, drugs that are not typically used in cancer therapy.